AI assistant
DANAHER CORP /DE/ — Director's Dealing 2021
Jun 24, 2021
29832_dirs_2021-06-24_c8d473c8-261b-48e9-9b15-006bb9a4e620.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3/A — Form 3/A
Issuer: Codex DNA, Inc. (DNAY)
CIK: 0001850079
Period of Report: 2021-06-17
Reporting Person: DANAHER CORP /DE/ (10% Owner)
Reporting Person: Danaher Innovation Center LLC (10% Owner)
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Series A Preferred Stock | $ | Common Stock (1751999) | Indirect | ||
| Series A-1 Preferred Stock | $ | Common Stock (542158) | Indirect |
Footnotes
F1: All shares of the preferred stock, par value $0.0001 per share, of the Issuer will automatically be converted on a one-for-one basis to shares of the Issuer's common stock, par value $0.0001 per share ("Common Stock"), prior to the closing of the Issuer's initial public offering of its Common Stock.
F2: Held by Danaher Innovation Center LLC. Danaher Innovation Center LLC is an indirect, wholly owned subsidiary of Danaher Corporation. The address of Danaher Innovation Center LLC is 2200 Pennsylvania Avenue, N.W., Suite 800W, Washington, DC 20037.